We are live on ! Find out more
DP

Diadema Partners Portfolio holdings

AUM $588M
1-Year Est. Return 182.75%
This Fund
S&P 500
This Quarter Est. Return
+9.46%
1 Year Est. Return
+182.75%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$233M
AUM Growth
–
Cap. Flow
+$273M
Cap. Flow %
117.2%
Top 10 Hldgs %
44.5%
Holding
107
New
107
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$9.19M
2
BMY icon
Bristol-Myers Squibb
BMY
+$8.94M
3
ONC
BeOne Medicines Ltd
ONC
+$6.13M
4
BPMC
Blueprint Medicines
BPMC
+$5.88M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$5.46M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 38.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DFTX
101
Definium Therapeutics
DFTX
$5.78B
$32.8K 0.01%
+4,710
New +$32.4K
LVTX
102
DELISTED
LAVA Therapeutics
LVTX
$20.5K 0.01%
+21,508
New +$33.8K
QTTB icon
103
CALL
Q32 Bio
QTTB
$466M
$19.3K 0.01%
+5,600
New +$177K
APVO icon
104
Aptevo Therapeutics
APVO
$5.12M
$17.5K 0.01%
+11
New +$31.6K
LRMR icon
105
Larimar Therapeutics
LRMR
$397M
$14.7K 0.01%
+3,800
New +$25.1K
LXRX icon
106
CALL
Lexicon Pharmaceuticals
LXRX
$1.03B
$591 ﹤0.01%
+800
New +$964
VTGN icon
107
CALL
VistaGen Therapeutics
VTGN
$9.89M
$590 ﹤0.01%
+200
New +$563
1 2 3 4
5

Similar funds

MC
Martin & Co Knoxville, Tennessee $587M AUM 16.39% 1-Year Est. Return
PFG
Premier Financial Group Eureka, California $587M AUM 21.88% 1-Year Est. Return
FMI
Frec Markets Inc San Francisco, California $587M AUM
EGWAG
Elwood & Goetz Wealth Advisory Group Athens, Georgia $589M AUM 19.26% 1-Year Est. Return
PFG
PAX Financial Group San Antonio, Texas $586M AUM 15.84% 1-Year Est. Return
GIM
Garden Investment Management Greenwich, Connecticut $586M AUM 15.35% 1-Year Est. Return
FL
Fourthstone LLC St Louis, Missouri $590M AUM 29.58% 1-Year Est. Return
BA
Bellwether Advisors Lincoln, Nebraska $590M AUM 35.66% 1-Year Est. Return

Diadema Partners's Q4 2024 Portfolio in Review

Q4 2024 is the first quarter with a 13F filing on record for Diadema Partners, which disclosed 107 positions worth $233M. Its ten largest holdings account for 44% of the portfolio.

Its largest position is AbbVie: 50,000 shares worth $8.88M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets.

  • Diadema Partners's largest Q4 2024 buy was AbbVie: 50,000 shares worth $8.88M.
  • Diadema Partners's ten largest holdings make up 44% of its $233M portfolio in Q4 2024.
  • Diadema Partners disclosed 107 positions in Q4 2024, its first 13F filing on record.

Based on Diadema Partners's 13F filing for Q4 2024, filed 14 Feb 2025.